Yingnan Si

473 total citations
18 papers, 334 citations indexed

About

Yingnan Si is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Yingnan Si has authored 18 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Biomedical Engineering. Recurrent topics in Yingnan Si's work include RNA Interference and Gene Delivery (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Extracellular vesicles in disease (4 papers). Yingnan Si is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Extracellular vesicles in disease (4 papers). Yingnan Si collaborates with scholars based in United States and Singapore. Yingnan Si's co-authors include Lufang Zhou, Margaret Liu, Seulhee Kim, Renata Jaskula‐Sztul, Yuanxin Xu, Herbert Chen, Kai Chen, James M. Markert, Yawen Tang and Eric Erquan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yingnan Si

18 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingnan Si United States 12 189 128 75 71 53 18 334
Seulhee Kim United States 10 183 1.0× 95 0.7× 51 0.7× 37 0.5× 35 0.7× 18 294
Kun Mi China 11 152 0.8× 117 0.9× 62 0.8× 37 0.5× 54 1.0× 19 355
Nana Nikolaishvili‐Feinberg United States 10 149 0.8× 102 0.8× 55 0.7× 29 0.4× 50 0.9× 16 316
Milena Guidi Italy 7 104 0.6× 70 0.5× 59 0.8× 39 0.5× 34 0.6× 23 280
Jaewan Jeon South Korea 11 139 0.7× 39 0.3× 58 0.8× 28 0.4× 25 0.5× 15 284
Zofia Pilch Poland 10 110 0.6× 177 1.4× 63 0.8× 182 2.6× 12 0.2× 21 367
Annunziata Nigro Italy 7 100 0.5× 136 1.1× 65 0.9× 172 2.4× 15 0.3× 11 316
Zuzanna Urban‐Wójciuk Poland 8 159 0.8× 143 1.1× 36 0.5× 222 3.1× 10 0.2× 13 427
Christina Schug Germany 14 174 0.9× 71 0.6× 62 0.8× 9 0.1× 23 0.4× 15 347

Countries citing papers authored by Yingnan Si

Since Specialization
Citations

This map shows the geographic impact of Yingnan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingnan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingnan Si more than expected).

Fields of papers citing papers by Yingnan Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingnan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingnan Si. The network helps show where Yingnan Si may publish in the future.

Co-authorship network of co-authors of Yingnan Si

This figure shows the co-authorship network connecting the top 25 collaborators of Yingnan Si. A scholar is included among the top collaborators of Yingnan Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingnan Si. Yingnan Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ernst, P, Seulhee Kim, Yingnan Si, et al.. (2024). mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer. Cancer Research. 84(23). 4049–4065. 7 indexed citations
2.
3.
Si, Yingnan, et al.. (2022). Process Improvement of Adeno-Associated Virus Production. SHILAP Revista de lepidopterología. 4. 24 indexed citations
4.
Si, Yingnan, et al.. (2022). Abstract 5958: CD276/CD47-targeted antibody-drug conjugates to treat triple-negative breast cancers. Cancer Research. 82(12_Supplement). 5958–5958. 1 indexed citations
5.
Si, Yingnan, Kai Chen, Seulhee Kim, et al.. (2022). Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers. Pharmaceutics. 14(1). 146–146. 15 indexed citations
6.
Si, Yingnan, Seulhee Kim, Tae Hyun Kim, et al.. (2022). Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines. 10(1). 130–130. 16 indexed citations
7.
Si, Yingnan, Seulhee Kim, Patrick Erñst, et al.. (2021). Antibody–Drug Conjugate to Treat Meningiomas. Pharmaceuticals. 14(5). 427–427. 7 indexed citations
8.
Si, Yingnan, Ya Zhang, Kai Chen, et al.. (2021). Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer. Cancers. 13(15). 3749–3749. 19 indexed citations
9.
Si, Yingnan, Ya Zhang, Ajeet Singh, et al.. (2021). Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines. 9(8). 882–882. 25 indexed citations
10.
Si, Yingnan, Seulhee Kim, Yun Lü, et al.. (2020). Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy. Cancer Gene Therapy. 28(7-8). 799–812. 29 indexed citations
11.
Si, Yingnan, et al.. (2020). Monoclonal antibody-based cancer therapies. Chinese Journal of Chemical Engineering. 30. 301–307. 10 indexed citations
12.
Si, Yingnan, Yuanxin Xu, Kai Chen, et al.. (2020). Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy. Engineering in Life Sciences. 21(1-2). 37–44. 28 indexed citations
13.
Si, Yingnan, Yuanxin Xu, Kai Chen, et al.. (2020). Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics. 12(11). 1079–1079. 18 indexed citations
14.
Si, Yingnan, Yawen Tang, Yun Lü, et al.. (2019). Novel biomanufacturing platform for large-scale and high-quality human T cells production. Journal of Biological Engineering. 13(1). 34–34. 13 indexed citations
15.
Si, Yingnan, Seulhee Kim, Eric Erquan Zhang, et al.. (2019). Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation. Biotechnology Journal. 15(1). e1900163–e1900163. 61 indexed citations
16.
Bao, Teng, Patrick Erñst, Yingnan Si, et al.. (2019). Intracellular metabolism analysis of Clostridium cellulovorans via modeling integrating proteomics, metabolomics and fermentation. Process Biochemistry. 89. 9–19. 8 indexed citations
17.
Xu, Ningning, Yingnan Si, Kah Yong Goh, et al.. (2019). Proteomics insight into the production of monoclonal antibody. Biochemical Engineering Journal. 145. 177–185. 11 indexed citations
18.
Si, Yingnan, Norio Yasui, Yichen Guo, et al.. (2018). Bioprocess development of antibody-drug conjugate production for cancer treatment. PLoS ONE. 13(10). e0206246–e0206246. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seulhee Kim Breakdown of academic impact, for papers by Kun Mi Breakdown of academic impact, for papers by Nana Nikolaishvili‐Feinberg Breakdown of academic impact, for papers by Milena Guidi Breakdown of academic impact, for papers by Jaewan Jeon Breakdown of academic impact, for papers by Zofia Pilch Breakdown of academic impact, for papers by Annunziata Nigro Breakdown of academic impact, for papers by Zuzanna Urban‐Wójciuk Breakdown of academic impact, for papers by Christina Schug
Rankless by CCL
2026